As Covid-19 lockdown measures continue across the world, unemployment rates have spiked, and several businesses have collapsed. Stimulus packages are…
The measures being implemented by governments across the world to control the spread of the Covid-19 are having devastating impact…
Cyxone has announced the screening of the first participant in the Phase II clinical trial to evaluate Rabeximod for treating Covid-19 patients. The trial is…
Mirum Pharmaceuticals has enrolled the first patient in its Phase IIb VISTAS study of volixibat in adult patients with primary sclerosing cholangitis (PSC), an idiopathic…
Drug discovery and development firm Knopp Biosciences has announced positive top-line results from a Phase II dose-ranging trial of a…
Biopharmaceutical firm Ampio Pharmaceuticals has announced the enrolment of 55% of the participants in its ongoing US Phase I clinical…
Clinical-stage biopharmaceutical firm Terns Pharmaceuticals has completed patient enrolment in Phase IIa LIFT study of TERN-101 for treating non-alcoholic steatohepatitis…
South Korean company Celltrion has reported data from Phase II clinical trials confirming that its Covid-19 treatment candidate, Regkirona (CT-P59;…
GEMTESA® (vibegron) is the first new oral medication indicated for the treatment of overactive bladder (OAB) with signs of urge…
OpenClinica is pleased to announce that it will be included in public television series In Depth, exhibiting its clinical trials…
ORGOVYX™ (relugolix) is the first and only oral gonadotropin-releasing hormone (GnRH) receptor antagonist indicated for the treatment of advanced prostate…
EVERSANA™ and Experic are pleased to announce that they will be partnering to aid life sciences companies in optimising clinical…
